GlassScriptPhysician profile
Ann M Sweet
NPI 1033141957
$5,154.15
in general payments reported to CMS, 2019-2025
20 companies · $1,297 in 2025
The $1,297 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $432 · 2022: $933 · 2023: $1,222 · 2024: $1,270 · 2025: $1,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,729 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,729.30 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,135.03 | 2021-2025 | Evenity, Enbrel, Tavneos |
| Abbvie INC. | $934.35 | 2021-2025 | |
| Janssen Biotech, INC. | $600.19 | 2021-2024 | Tremfya |
| Ucb, INC. | $445.16 | 2021-2025 | Bimzelx, Cimzia |
| Astrazeneca Pharmaceuticals LP | $390.70 | 2021-2024 | Saphnelo |
| Aurinia Pharma U.S., INC. | $344.57 | 2021-2024 | Lupkynis |
| Glaxosmithkline, LLC. | $276.03 | 2021-2025 | Benlysta |
| Pfizer INC. | $243.27 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $215.34 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.65 | 2021-2024 | Ofev |
| Fresenius Kabi USA, LLC | $96.77 | 2023-2025 | Idacio |
| Alexion Pharmaceuticals, INC. | $82.14 | 2024-2025 | Strensiq |
| Daiichi Sankyo INC. | $72.27 | 2021-2024 | Injectafer |
| Sobi, INC | $59.82 | 2024-2025 | |
| Lilly USA, LLC | $42.05 | 2022-2023 | Taltz |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $31.76 | 2025 | Gazyva |
| Organon LLC | $30.31 | 2025 | Hadlima |
| Octapharma USA, INC. | $19.66 | 2022 | |
| Horizon Therapeutics Plc | $16.73 | 2021 | |
| Ani Pharmaceuticals, INC. | $15.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Sweet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.